Richard Glynne

Richard Glynne

Company: Lycia Therapeutics

Job title: Chief Scientific Officer


Industry Panel Discussion: PROTACs & Beyond: Predicting the Future Landscape of Targeted Protein Degradation 10:00 am

What are the key ingredients for building an effective team to successfully discover and develop protein degraders? How do we optimize translation to advance protein degraders towards clinical development? What are the benefits and advantages of next generation ‘TAC’ protein degraders? How do we unleash the full potential of targeted protein degradation to go beyond…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.